IE 11 is not supported. For an optimal experience visit our site on another browser.

Radient Pharmaceuticals is Today's Focus Stock on

/ Source: GlobeNewswire

DALLAS, June 14, 2011 (GLOBE NEWSWIRE) -- announces an investment report featuring Radient Pharmaceuticals Corp. (AMEX:RPC). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at:

Radient Pharmaceuticals Corp. (RPC) is a Tustin, Calif.-based company focused on the discovery, development and commercialization of diagnostic tests that help physicians answer clinical questions related to early disease-state detection, treatment strategy and the monitoring of disease progression or recurrence. The Company offers its FDA-cleared In Vitro Diagnostic Onko-SureTest Kits for colon-rectal cancer recurrence monitoring.

This newsletter has been helping traders make great investment decisions on RPC; click here for a 25% discount offer.

In the report, the analyst notes:

"Shares of RPC spiked more than 19% to close Monday at $0.25. About 13.98 million shares have traded hands during the session, versus the 10-day average volume of 2.87 million. PMI has so far reached a 52-week high of $4.68, its 52-week low being $0.14. The stock is currently below its 50-day and 200-day moving averages of $0.31 and $0.52, respectively."

"RPC shares were boosted last week after Dr. Umesh Bhatia Ph.D, a senior advisor for RPC in India, revealed that his group has secured a major new partnership that should clearly benefit RPC and is expected to impact the Company's bottom line."

To read the entire report visit:

See what investors are saying about RPC at

Get breaking news on RPC at is a small-cap research and investment commentary provider. strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. is a Web site wholly owned by BlueWave Advisors, LLC. Neither nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site,, for complete risks and disclosures.

CONTACT: Brian Johnson 1-888-307-2850